History

2008

CardioTech International Inc. divests CDT and invests in a corporate re-Branding strategy to align core competencies and intrinsic corporate values to be a world-class technology company targeted to customer driven solutions across the medical device industry. 

AdvanSource Biomaterials is created as a wholly owned subsidiary of CardioTech International Inc.

2007

ChronoFlex® - based CardioPass™ synthetic coronary artery bypass graft enters a clinical trial in Europe to obtain CE Mark approval.  Divestment of Gish Biomedical Inc.

2004

Joint Venture with Implant Sciences Corporation to participate in the funding of CorNova, Inc. CorNova was formed to develop a novel coronary drug eluting stent using the combined capabilities and technology of CorNova, Implant Sciences and CardioTech. The Company currently has a 17% equity interest in the issued and outstanding common and preferred stock of CorNova.  

2003

The Company merges with Gish Biomedical Inc., manufacturers of single use cardiopulmonary bypass products that have a disposable component.

2001

The Company acquires Catheter and Disposables Technology (CDT) an original equipment manufacturer and supplier of private-label advanced disposable medical devices from concept to finished packaged and sterilized products.

1993

CardioTech International Inc. is founded as a subsidiary of PolyMedica Corporation.  ChronoFlex ® proprietary polyurethanes sold under the tradenames: ChronoFlex®, ChronoThane™, HydroThane™, ChronoFilm™, HydroMed™ and Hydroslip™, and are used by our customers for use in both acute and chronically implanted devices such as stents, artificial hearts, and vascular ports.